$2.18 -0.07 (-3.11%)
11/25/2009 11:59 AM

DURECT Corp (DRRX)

CAPS Rating: 3 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Featured Broker Partners